A randomised trial of secondary prophylaxis using granulocyte colony-stimulating factor ('SPROG' trial) for maintaining dose intensity of standard adjuvant chemotherapy for breast cancer by the Anglo-Celtic Cooperative Group and NCRN - Leonard, RC; Mansi, JL; Keerie, C (Annals of oncology: official journal of the European Society for Medical Oncology /ESMO, 2015)
et al.